
24/07/2025
Sneak Preview JMDR August 2025 issue:
India’s regulatory framework for software as a medical device (SaMD)
This article by Sundeep Agarwal offers an in-depth look into India's regulatory framework for SaMD, serving as a critical guide for developers, manufacturers, and importers aiming to bring their digital health solutions to the Indian market successfully.
India’s regulatory landscape for SaMD is rapidly evolving in response to the healthcare sector’s growing reliance on digital innovations such as artificial intelligence, wearables, and telehealth.
Under the Medical Devices Rules, 2017, the Central Drugs Standard Control Organization has established a comprehensive framework to govern SaMD throughout the total product lifecycle - from design and development to post-market surveillance. This includes risk classifications, stringent quality management requirements, clinical investigations for higher-risk devices, and a detailed registration process.
With recent mandates for version tracking, mandatory labelling, and continuous monitoring, both domestic and international stakeholders must navigate a dynamic, compliance-driven environment.
------
Also in the August issue:
Regulatory news updates from:
Australia, Brazil, China, Denmark, Egypt, EU, France, Germany, Hong Kong, India, Japan, Malaysia, Mexico, Philippines, Portugal, Singapore, South Africa, Switzerland, UK, Ukraine, and the USA....